JP2005533789A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533789A5
JP2005533789A5 JP2004513217A JP2004513217A JP2005533789A5 JP 2005533789 A5 JP2005533789 A5 JP 2005533789A5 JP 2004513217 A JP2004513217 A JP 2004513217A JP 2004513217 A JP2004513217 A JP 2004513217A JP 2005533789 A5 JP2005533789 A5 JP 2005533789A5
Authority
JP
Japan
Prior art keywords
mono
poly
cyclic
substituents
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004513217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533789A (ja
JP4718172B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/018262 external-priority patent/WO2003106381A2/en
Publication of JP2005533789A publication Critical patent/JP2005533789A/ja
Publication of JP2005533789A5 publication Critical patent/JP2005533789A5/ja
Application granted granted Critical
Publication of JP4718172B2 publication Critical patent/JP4718172B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004513217A 2002-06-12 2003-06-11 ヒトａｄａｍ−１０インヒビター Expired - Fee Related JP4718172B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38832602P 2002-06-12 2002-06-12
US60/388,326 2002-06-12
PCT/US2003/018262 WO2003106381A2 (en) 2002-06-12 2003-06-11 Human adam-10 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010142096A Division JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトａｄａｍ−１０インヒビター

Publications (3)

Publication Number Publication Date
JP2005533789A JP2005533789A (ja) 2005-11-10
JP2005533789A5 true JP2005533789A5 (https=) 2011-02-24
JP4718172B2 JP4718172B2 (ja) 2011-07-06

Family

ID=29736461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004513217A Expired - Fee Related JP4718172B2 (ja) 2002-06-12 2003-06-11 ヒトａｄａｍ−１０インヒビター
JP2010142096A Pending JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトａｄａｍ−１０インヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010142096A Pending JP2010265276A (ja) 2002-06-12 2010-06-22 ヒトａｄａｍ−１０インヒビター

Country Status (7)

Country Link
US (5) US7629341B2 (https=)
EP (3) EP2436676A1 (https=)
JP (2) JP4718172B2 (https=)
AU (2) AU2003237532B2 (https=)
CA (1) CA2485346C (https=)
ES (1) ES2425013T3 (https=)
WO (1) WO2003106381A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517884B2 (en) * 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
EP2436676A1 (en) * 2002-06-12 2012-04-04 Symphony Evolution, Inc. Human adam-10 inhibitors
US8088737B2 (en) 2003-04-04 2012-01-03 Incyte Corporation Compositions, methods and kits relating to Her-2 cleavage
EP1623995A1 (en) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibitors of L1 and ADAM10 for the treatment of carcinomas
US20070190079A1 (en) * 2004-10-29 2007-08-16 Kalypsys, Inc. Methods for the selective modulation of ppar
CA2585172C (en) * 2004-10-29 2014-08-12 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as modulators of ppar
JP2008535854A (ja) * 2005-04-07 2008-09-04 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド 癌の診断、検出および処置におけるａｄａｍ１０
HUE040020T2 (hu) * 2005-10-25 2019-02-28 Kalypsys Inc PPAR modulátorok sói és eljárások metabolikus betegségek kezelésére
WO2007084488A2 (en) 2006-01-13 2007-07-26 Vanderbilt University Adam10 and its uses related to infection
CN100506804C (zh) * 2006-01-26 2009-07-01 于学敏 羟苯磺酸烷基吡嗪药物及其制备方法和应用
US20070249519A1 (en) * 2006-04-20 2007-10-25 Kalypsys, Inc. Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
AR060937A1 (es) * 2006-05-16 2008-07-23 Kalypsys Inc Compuestos biciclicos sustituidos con sulfonilo como moduladores de ppar
WO2008091863A1 (en) * 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
WO2009052200A2 (en) * 2007-10-16 2009-04-23 Symphony Evolution, Inc. Human adam-10 inhibitors
WO2010042867A2 (en) 2008-10-09 2010-04-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Activators of human pyruvate kinase
CA2774389A1 (en) 2009-10-01 2011-04-07 Symphony Evolution, Inc. Methods of treating aneurysmal dilatation, blood vessel wall weakness and specifically abdominal aortic and thoracic aneurysm using matrix metalloprotease-2 inhibitors
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
JP5888667B2 (ja) * 2010-04-30 2016-03-22 国立大学法人名古屋大学 Ａｄａｍ作用阻害物質のスクリーニング方法、仮足の保持方法、仮足保持剤、仮足の制御物質のスクリーニング方法、及びａｄａｍ作用阻害剤
EP2637679A4 (en) 2010-11-09 2015-09-23 Univ Chicago ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASES AND THERAPEUTICS
WO2014028334A1 (en) * 2012-08-11 2014-02-20 Symphony Evolution, Inc. Selective mmp inhibitors
EP3097420A4 (en) * 2014-01-24 2018-01-17 Ntercept, LLC Methods and compositions for immune dis-inhibition
EA035898B1 (ru) 2014-10-03 2020-08-28 НАНОТИКС, ЭлЭлСи Композиции и способы для ингибирования биологической активности растворимых биомолекул
EP3328362A4 (en) 2015-07-29 2019-03-06 Nanotics, LLC MODULAR COMPOSITIONS FOR THE DISPOSAL OF SOLUBLE BIOMOLECULES AND RELATED METHODS
US11065345B2 (en) 2017-01-04 2021-07-20 Nanotics, Llc Methods for assembling scavenging particles
CN108947850B (zh) * 2018-07-23 2021-05-18 蚌埠中实化学技术有限公司 一种3,4,5-三氟苯胺的制备方法
EP3969035A4 (en) 2019-05-14 2023-06-21 Werewolf Therapeutics, Inc. SEPARATION UNITS AND METHODS AND THEIR USE
MX2022005666A (es) 2019-11-14 2022-10-07 Werewolf Therapeutics Inc Polipeptidos de citocina activables y metodos de uso de los mismos.
CN113563235B (zh) * 2021-07-28 2023-04-11 上海毕得医药科技股份有限公司 一种3-(卤代苯氧基)苯磺酰氯衍生物的合成方法
US20250177333A1 (en) * 2022-03-08 2025-06-05 Nova Southeastern University Method for treating rheumatoid arthritis (ra) using an enzyme-and substrate selective exosite inhibitor of a disintegrin and metalloprotease 10 (adam10)

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1016245A (en) * 1962-11-06 1966-01-05 Ici Ltd Manufacture of polysulphones
US4213775A (en) * 1977-07-28 1980-07-22 Ube Industries, Ltd. Diphenyl ether derivatives and herbicidal compositions containing the same
DE3107700A1 (de) * 1981-02-28 1982-09-16 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von aromatischen sulfohalogeniden
EP0594590B1 (en) * 1990-03-01 1995-09-06 The Upjohn Company Ruminal bacterium for preventing acute lactic acidosis
DE4015834A1 (de) * 1990-05-17 1991-11-21 Bayer Ag Phenoxyphenylsulfonylverbindungen
US5215549A (en) * 1991-05-08 1993-06-01 Mobil Oil Corporation Thioester derived hindered phenols and aryl-amines as antioxidant and antiwear additives
DE4327026A1 (de) 1993-08-12 1995-02-16 Bayer Ag Arylsulfonyloxyphosphonsäurederivate
ES2153031T4 (es) 1995-04-20 2001-05-16 Pfizer Derivados del acido arilsulfonil hidroxamico como inhibidores de mmp y tnf.
JP3837761B2 (ja) * 1995-08-04 2006-10-25 住友精化株式会社 ハロベンゼンスルホニルクロリド類の製造方法
DE19537334A1 (de) * 1995-10-09 1997-04-10 Hoechst Ag Antiadhäsive Piperidin- und Pyrrolidin-Carbonsäuren
ES2233275T3 (es) * 1995-12-08 2005-06-16 Agouron Pharmaceuticals, Inc. Intermediarios que sirven para la preparacion de inhibidores de metaloproteinasas.
US5753653A (en) * 1995-12-08 1998-05-19 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
KR100339296B1 (ko) * 1996-08-28 2002-06-03 데이비드 엠 모이어 헤테로고리성 메탈로프로테아제 억제제
US5935792A (en) 1996-08-29 1999-08-10 The Regents Of The University Of California KUZ, a novel family of metalloproteases
WO1998027069A1 (en) 1996-12-17 1998-06-25 Fujisawa Pharmaceutical Co., Ltd. Piperazine compounds as inhibitors of mmp or tnf
PL334846A1 (en) * 1997-01-23 2000-03-27 Hoffmann La Roche Sulphamidic inhibitors of metaloproteases
EP0960098A1 (en) * 1997-02-11 1999-12-01 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
WO1998043963A1 (en) 1997-04-01 1998-10-08 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US5922546A (en) 1997-08-25 1999-07-13 Smithkline Beecham Corporation Human disintegrin metalloprotease KUZ gene
JP4327915B2 (ja) * 1998-03-30 2009-09-09 株式会社デ・ウエスタン・セラピテクス研究所 スルフォンアミド誘導体
GT199900044A (es) * 1998-04-10 2000-09-14 Procedimientos para preparar haluros de fenoxifenilsulfonilo.
CN1301265A (zh) 1998-05-14 2001-06-27 杜邦药品公司 新的用作金属蛋白酶抑制剂的取代的芳基异羟肟酸
ES2242402T3 (es) * 1998-08-12 2005-11-01 Pfizer Products Inc. Inhibidores de tace.
US6509337B1 (en) * 1998-09-17 2003-01-21 Pfizer Inc. Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors
AR035313A1 (es) 1999-01-27 2004-05-12 Wyeth Corp Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
JP2000247975A (ja) 1999-02-25 2000-09-12 Nissan Chem Ind Ltd ヘテロ環縮合ピリミジノン誘導体及びそれらを含む除草剤
US6387901B1 (en) * 1999-07-06 2002-05-14 Pfizer Inc Alkyne containing metalloproteinase inhibitors
EP1081137A1 (en) * 1999-08-12 2001-03-07 Pfizer Products Inc. Selective inhibitors of aggrecanase in osteoarthritis treatment
EP1252143A1 (en) 2000-01-27 2002-10-30 American Cyanamid Company Method for preparing alpha-sulfonyl hydroxamic acid derivatives
US6664291B2 (en) * 2000-03-31 2003-12-16 Pfizer, Inc. Malonamic acids and derivatives thereof as thyroid receptor ligands
JP4635162B2 (ja) * 2000-04-27 2011-02-16 独立行政法人理化学研究所 芳香族ジアミンの製造方法及び芳香族ジアミン化合物
WO2002067866A2 (en) 2001-02-27 2002-09-06 Axys Pharmaceuticals, Inc. Piperazine derivatives as metalloprotease inhibitors
CA2357110A1 (en) 2001-04-11 2002-10-11 American Cyanamid Company Method for the treatment of polycystic kidney disease
EP1389204A4 (en) 2001-04-26 2005-03-23 Kolon Inc NEW SULPHONAMIDE DERIVATIVES, THEIR INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS
US6399823B1 (en) * 2001-04-30 2002-06-04 General Electric Company Method for producing phosgene
BR0213736A (pt) * 2001-11-01 2004-10-19 Wyeth Corp ácidos hidroxâmicos de sulfonamida de arila alênica como metaloproteinase matriz e inibidores de tace
CN1173960C (zh) 2001-12-06 2004-11-03 中国人民解放军军事医学科学院毒物药物研究所 取代六元氮杂环类化合物及其作为神经调节剂的用途
ES2331177T3 (es) * 2001-12-14 2009-12-23 Exelixis, Inc. Inhibidores de adam-10 humana.
WO2003055851A1 (en) 2001-12-27 2003-07-10 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
US7488754B2 (en) * 2002-04-05 2009-02-10 Wyeth Method for the treatment of polycystic kidney disease
EP2436676A1 (en) 2002-06-12 2012-04-04 Symphony Evolution, Inc. Human adam-10 inhibitors
MXPA05001603A (es) * 2002-08-13 2005-04-25 Warner Lambert Co Derivados monociclicos como inhibidores de metaloproteinasa de matriz.
EP1400244A1 (en) * 2002-09-17 2004-03-24 Warner-Lambert Company LLC New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
CA2513716A1 (en) * 2003-02-14 2004-08-26 Applied Research Systems Ars Holding N.V. Piperazine-2-carboxamide derivatives
BRPI0407587A (pt) * 2003-02-18 2006-02-14 Pfizer inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
US7563781B2 (en) * 2005-01-14 2009-07-21 Janssen Pharmaceutica Nv Triazolopyrimidine derivatives
JP2009509923A (ja) * 2005-08-26 2009-03-12 メシルジーン、インコーポレイテッド ヒストンデアセチラーゼのベンゾジアゼピン及びベンゾピペラジン類似体阻害薬
EP1937632A1 (en) 2005-10-06 2008-07-02 Astra Zeneca AB Novel compounds

Similar Documents

Publication Publication Date Title
JP2005533789A5 (https=)
JP2006505543A5 (https=)
JP2012510502A5 (https=)
JP2024504932A5 (https=)
JP2010511626A5 (https=)
JP2007503202A5 (https=)
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
JP2006151984A5 (https=)
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
JP2005523922A5 (https=)
JP2005501904A5 (https=)
RU2012112050A (ru) Производные дигидроптеридинона, способ их получения и фармацевтическое применение
JP2005539045A5 (https=)
JP2008509187A5 (https=)
JP2010501478A5 (https=)
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
JP2005526097A5 (https=)
AR050518A1 (es) Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv
AR064318A1 (es) Compuesto y composicion derivada de aril sulfamida, uso del compuesto y proceso para la preparacion del compuesto
JP2020502116A5 (https=)
RU2401267C2 (ru) Замещенные производные бензохинолизина
JP2004518658A5 (https=)
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
AR065297A1 (es) Formulaciones biodisponibles de compuestos heterociclicos
JP2022507795A5 (https=)